PERCEPTIVE ADVISORS LLC

Average Profitability
19.15%
Insider Buys Quantity
99
Insider Buys Sum
$777.65M
Insider Sells Quantity
19
Insider Sells Sum
$33.71M

Insider Activity of PERCEPTIVE ADVISORS LLC

According to the SEC Form 4 filings, PERCEPTIVE ADVISORS LLC, being in a position of

  1. 10 percent owner at Aldeyra Therapeutics, Inc.,
    оver the last 12 months, has bought 682265 shares for $2.77M, and sold 0 shares,
    over all time since 2015-10-20, has bought 11979280 shares for $76.17M, and sold 2756499 shares for $4.45M.

The largest purchase of all time was on 2021-06-09 and amounted to 5500000 shares of Nautilus Biotechnology, Inc. for $55M.

The largest sale of all time was on 2016-08-25 and amounted to 2200000 shares of Amicus Therapeutics, Inc. for $14.98M.

Biography of PERCEPTIVE ADVISORS LLC

No biography is available at this moment.

2024-08-12PurchaseMeiraGTx Holdings plc
MGTX
1.25M
1.9341%
$4.00$5M+5.75%
2024-04-05PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
37,712
0.0643%
$4.74$178,755-11.23%
2024-04-04PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
140,281
0.2374%
$4.67$655,112-10.26%
2024-04-03PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
309,847
0.5185%
$4.09$1.27M+1.45%
2024-04-02PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
186,051
0.3061%
$3.44$640,015+18.31%
2024-04-01PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
8,374
0.0141%
$3.25$27,216+28.13%
2024-02-01PurchaseAstria Therapeutics, Inc.
ATXS
director
2.48M
5.6893%
$12.09$30M-16.45%
2024-01-11PurchaseSolid Biosciences Inc.
SLDB
3.41M
12.2033%
$5.53$18.86M+5.22%
2023-12-29PurchaseAthira Pharma, Inc.
ATHA
163,954
0.4272%
$2.38$390,211+6.25%
2023-12-29PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
115,774
0.2752%
$7.24$838,204-21.72%
2023-12-28PurchaseAthira Pharma, Inc.
ATHA
409,598
1.0852%
$2.44$999,419+4.08%
2023-12-28PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
126,116
0.2934%
$7.08$892,901-22.67%
2023-12-27PurchaseAthira Pharma, Inc.
ATHA
32,134
0.0833%
$2.28$73,266+10.87%
2023-12-27PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
79,726
0.1901%
$7.20$574,027-21.42%
2023-12-26PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
54,652
0.1301%
$6.49$354,691-12.92%
2023-12-22PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
250,000
0.5943%
$6.67$1.67M-16%
2023-12-21PurchaseAstria Therapeutics, Inc.
ATXS
director
740,000
2.0257%
$6.20$4.59M+79.12%
2023-12-21PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
200,000
0.4555%
$6.17$1.23M-12.09%
2023-12-19PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
277,008
0.6854%
$5.36$1.48M+10.17%
2023-12-18PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
456,923
1.0714%
$5.41$2.47M+3.28%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.